Related Experiment Video
Updated: Jun 27, 2026

Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption
Published on: August 16, 2016
Catecholamines: the cardiovascular and neuroendocrine system
Autonomic dysfunction and neuroendocrine activation are key in heart failure progression. Understanding sympathetic nervous system overactivity is vital for predicting survival and developing effective treatments for heart disease.
Area of Science:
- Cardiology
- Neuroendocrinology
- Autonomic Nervous System
Background:
- Profound autonomic dysfunction and neuroendocrine activation characterize heart failure progression.
- Sympathetic nervous system activation is a generalized process in heart failure, driven by altered afferent and chemoceptor inputs.
- Catecholamine levels, particularly noradrenaline, significantly increase in advanced heart failure patients.
Purpose of the Study:
- To elucidate the role of autonomic dysfunction and neuroendocrine activation in heart failure.
- To understand the mechanisms driving neurohumoral activation in cardiovascular disease.
- To highlight the clinical relevance of neuroadrenergic abnormalities in heart failure management.
Main Methods:
- Development of efficient methods to quantify sympathetic cardiovascular influences.
- Measurement of neuroendocrine indices in patients with heart disease.
- Analysis of catecholamine and noradrenaline levels in renal and cardiac circulation.
Main Results:
- Sympathoneural activation was identified as an independent predictor of patient survival.
- Quantified significant increases in renal and cardiac catecholamine overflow in impaired heart failure patients.
- Established the link between neuroadrenergic abnormalities and disease progression.
Conclusions:
- Autonomic dysfunction and neuroendocrine activation are critical pathophysiological components of congestive heart failure.
- Sympathetic nervous system overactivity independently predicts survival in heart failure patients.
- Targeting neuroadrenergic abnormalities offers a therapeutic strategy for managing heart failure.
More Related Videos
06:40Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System
Published on: May 22, 2018
06:30Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats
Published on: September 11, 2018
Related Concept Videos
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
An Overview of the Endocrine System
The endocrine system collaborates...
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...